11-986801-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_012305.4(AP2A2):c.979G>A(p.Val327Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,613,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012305.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP2A2 | ENST00000448903.7 | c.979G>A | p.Val327Ile | missense_variant | Exon 9 of 22 | 1 | NM_012305.4 | ENSP00000413234.3 | ||
AP2A2 | ENST00000332231.9 | c.982G>A | p.Val328Ile | missense_variant | Exon 9 of 22 | 1 | ENSP00000327694.5 | |||
AP2A2 | ENST00000528815.5 | n.982G>A | non_coding_transcript_exon_variant | Exon 9 of 21 | 2 | ENSP00000431630.1 | ||||
AP2A2 | ENST00000687792.1 | n.979G>A | non_coding_transcript_exon_variant | Exon 9 of 21 | ENSP00000508951.1 | |||||
AP2A2 | ENST00000687890.1 | n.979G>A | non_coding_transcript_exon_variant | Exon 9 of 21 | ENSP00000510756.1 | |||||
AP2A2 | ENST00000693238.1 | n.979G>A | non_coding_transcript_exon_variant | Exon 9 of 20 | ENSP00000510648.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152162Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000889 AC: 22AN: 247516Hom.: 0 AF XY: 0.0000892 AC XY: 12AN XY: 134518
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1460896Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 726678
GnomAD4 genome AF: 0.000112 AC: 17AN: 152162Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.982G>A (p.V328I) alteration is located in exon 9 (coding exon 9) of the AP2A2 gene. This alteration results from a G to A substitution at nucleotide position 982, causing the valine (V) at amino acid position 328 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at